Welcome to Novorex, the innovative bioventure leveraging the power of artificial intelligence and biophysical analysis to revolutionize the new drug development.

Our mission is to enable seamless drug discovery through our advanced AI-based drug development platform and expertise in Fragment-Based Drug Discovery(FBDD).
With our approach, we are able to efficiently and accurately identify promising drug candidates, including undruggable targets, and accelerate the drug discovery process, reducing the time and costs associated with traditional High-Throughput Screening(HTS) methods. Our commitment is to accelerate the discovery of new therapies that address unmet medical needs and improve patient outcomes, with a focus on oncology, CNS, and other critical area.

At Novorex, we are dedicated to delivering innovative solutions to the most challenging drug development problems. Our team of world-class scientists, engineers, and industry experts work closely with our partners and collaborators to expedite new drug discovery programs that meet their specific needs and goals. We use cutting-edge AI technology and state-of-the-art facilities to rapidly identify promising drug candidates and bring them to market faster than ever before.

Whether you are a pharmaceutical company looking to collaborate or a researcher seeking to develop novel therapeutics, Novorex is your trusted partner for innovative drug development solutions. Contact us today to learn more about us and how we can help you achieve your drug development goals.